All terms in BAO
| Label | Id | Description |
|---|---|---|
| EC 1.11.2.2 (myeloperoxidase) inhibitor | CHEBI_79093 | |
| EC 5.4.3.* (intramolecular transferase transferring amino groups) inhibitor | CHEBI_76829 | |
| EC 3.2.1.31 (beta-glucuronidase) inhibitor | CHEBI_76822 | |
| EC 5.1.1.* (racemases acting on amino acids and derivatives) inhibitor | CHEBI_76828 | |
| distributed | PATO_0001566 | [A spatial pattern inhering in a bearer by virtue of the bearer's being spread out or scattered about or divided up.] |
| chikungunya | DOID_0050012 | [A viral infectious disease that results_in infection located_in joint, has_material_basis_in Chikungunya virus, which is transmitted_by Aedes mosquito bite. The infection has_symptom fever, has_symptom arthralgia, and has_symptom maculopapular rash.] |
| one-hybrid assay | BAO_0002490 | [The one-hybrid variation of the hybrid screening technique is designed to investigate protein-DNA interactions and uses a single fusion protein in which the AD is linked directly to the binding domain.] |
| hybrid screening | BAO_0002489 | [Refers to variations on the two-hybrid technique, which measures activation of a reporter gene caused by binding between fusion proteins or other molecular entities.] |
| three-hybrid assay | BAO_0002491 | [RNA-protein interactions have been investigated through a three-hybrid variation of the two-hybrid technique. In this case, a hybrid RNA molecule serves to adjoin together the two protein fusion domains which are not intended to interact with each other but rather the intermediary RNA molecule (through their RNA-binding domains).] |
| two-hybrid assay | BAO_0002492 | [A molecular biology technique used to discover protein-protein interactions and protein-DNA interactions by testing for physical interactions (such as binding) between two proteins or a single protein and a DNA molecule, respectively. The premise behind the test is the activation of downstream reporter gene(s) by the binding of a transcription factor onto an upstream activating sequence (UAS). For two-hybrid screening, the transcription factor is split into two separate fragments, called the binding domain (BD) and activating domain (AD). The BD is the domain responsible for binding to the UAS and the AD is the domain responsible for the activation of transcription.] |
| carbohydrate metabolism disease | DOID_0050013 | [An acquired metabolic disease that is characterized by abnormal carbohydrate metabolism.] |
| osteoarthritis | DOID_8398 | [An arthritis that has_material_basis_in worn out cartilage located_in joint.] |
| anti-inflammatory agent | CHEBI_67079 | |
| propidium iodide exclusion | BAO_0002482 | [Dye uptake assays using neutral red, trypan blue and fluorescent compounds such as propidium iodide are traditional methods to assess cell viability and membrane damage. Trypan blue and fluorescent compounds such as propidium iodide are excluded by healthy, functional cell membranes but are able to traverse damaged cell membranes thereby preferentially staining dead cells.] |
| dye exclusion method | BAO_0002481 | [Dye staining method in which the dye is excluded from particular cells, usually due to the presence of an intact plasma membrane.] |
| vital staining of cells | BAO_0002483 | |
| vital dye staining | BAO_0002480 | [Method that employs a stain that is capable of entering and staining a living cell without causing an injury.] |
| cannabinoid receptor agonist | CHEBI_67072 | |
| EC 4.3.1.* (ammonia-lyase) inhibitor | CHEBI_76832 | |
| vital staining of organelles | BAO_0002484 |